Toxoplasma gondii: Impaired maturation and pro-inflammatory response of dendritic cells in MIF-deficient mice favors susceptibility to infection

Experimental Parasitology

Volumn 126, Issue 3, 2010, Pages 348-358

  Terrazas, Cesar A ^a   Juarez, Imelda ^a   Terrazas, Luis I ^a   Saavedra, Rafael ^b   Calleja, Elsa A ^a   Rodriguez Sosa, Miriam ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

Author keywords

Dendritic cells; Macrophage migration inhibitory factor; Toxoplasma gondii

Indexed keywords

INTERLEUKIN 12; MACROPHAGE MIGRATION INHIBITION FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; HLA ANTIGEN CLASS 2; ISOMERASE; MIF PROTEIN, MOUSE; PARASITE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; HOST RESISTANCE; IMMUNOMODULATION; INFECTION RESISTANCE; INNATE IMMUNITY; MALE; MESENTERY LYMPH NODE; MOUSE; MOUTH INFECTION; NONHUMAN; PRIORITY JOURNAL; TOXOPLASMA GONDII; TOXOPLASMOSIS; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BRAIN; C57BL MOUSE; DISEASE COURSE; DISEASE PREDISPOSITION; GENETICS; GERMFREE ANIMAL; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; KNOCKOUT MOUSE; LIVER; METABOLISM; PARASITOLOGY; PATHOLOGY; PHYSIOLOGY; TOXOPLASMA;

ANIMALS; ANTIGENS, PROTOZOAN; BRAIN; DENDRITIC CELLS; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERLEUKIN-12; INTRAMOLECULAR OXIDOREDUCTASES; LIVER; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; SPECIFIC PATHOGEN-FREE ORGANISMS; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; UP-REGULATION;

MUS; TOXOPLASMA GONDII;

EID: 77956234775     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2010.03.009     Document Type: Article

References (46)

1. Alexander J., Scharton-Kersten T.M., Yap G., Roberts C.W., Liew F.Y., Sher A. Mechanisms of innate resistance to Toxoplasma gondii infection. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1997, 352:1355-1359.
2. Aliberti J., Sher A. Role of G-protein-coupled signaling in the induction and regulation of dendritic cell function by Toxoplasma gondii. Microbes Infect. 2002, 4:991-997.
3. Aliberti J. Host persistence: exploitation of anti-inflammatory pathways by Toxoplasma gondii. Nat. Rev. Immunol. 2005, 5:162-170.
4. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000, 18:767-811.
5. Bernhagen J., Calandra T., Mitchell R.A., Martin S.B., Tracey K.J., Voelter W., Manogue K.R., Cerami A., Bucala R. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993, 365:756-759.
6. Bernhagen J., Krohn R., Lue H., Gregory J.L., Zernecke A., Koenen R.R., Dewor M., Georgiev I., Schober A., Leng L., Kooistra T., Fingerle-Rowson G., Ghezzi P., Kleemann R., McColl S.R., Bucala R., Hickey M.J., Weber C. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat. Med. 2007, 13:587-596.
7. Bliss S.K., Marshall A.J., Zhang Y., Denkers E.Y. Human polymorphonuclear leukocytes produce IL-12, TNF-alpha, and the chemokines macrophage-inflammatory protein-1 alpha and -1 beta in response to Toxoplasma gondii antigens. J. Immunol. 1999, 162:7369-7375.
8. Bliss S.K., Butcher B.A., Denkers E.Y. Rapid recruitment of neutrophils containing prestored IL-12 during microbial infection. J. Immunol. 2000, 165:4515-4521.
9. Bourguin I., Moser M., Buzoni-Gatel D., Tielemans F., Bout D., Urbain J., Leo O. Murine dendritic cells pulsed in vitro with Toxoplasma gondii antigens induce protective immunity in vivo. Infect. Immun. 1998, 66:4867-4874.
10. Bozza M., Satoskar A.R., Lin G., Lu B., Humbles A.A., Gerard C., David J.R. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J. Exp. Med. 1999, 189:341-346.
11. Burger-Kentischer A., Goebel H., Seiler R., Fraedrich G., Schaefer H.E., Dimmeler S., Kleemann R., Bernhagen J., Ihling C. Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis. Circulation 2002, 105:1561-1566.
12. Calandra T., Echtenacher B., Roy D.L., Pugin J., Metz C.N., Hultner L., Heumann D., Mannel D., Bucala R., Glauser M.P. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat. Med. 2000, 6:164-170.
13. Chamorro S., Garcia-Vallejo J.J., Unger W.W., Fernandes R.J., Bruijns S.C., Laban S., Roep B.O., t Hart B.A., van Kooyk Y. TLR triggering on tolerogenic dendritic cells results in TLR2 up-regulation and a reduced proinflammatory immune program. J. Immunol. 2009, 183:2984-2994.
14. Denkers E.Y., Gazzinelli R.T. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin. Microbiol. Rev. 1998, 11:569-588.
15. Denkers, E.Y., 2010. Toll-like receptor initiated host defense against Toxoplasma gondii. J. Biomed. Biotechnol. 737125 (7 pages).
16. Donnelly S.C., Haslett C., Reid P.T., Grant I.S., Wallace W.A., Metz C.N., Bruce L.J., Bucala R. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat. Med. 1997, 3:320-323.
17. Flores M., Saavedra R., Bautista R., Viedma R., Tenorio E.P., Leng L., Sanchez Y., Juarez I., Satoskar A.A., Shenoy A.S., Terrazas L.I., Bucala R., Barbi J., Satoskar A.R., Rodriguez-Sosa M. Macrophage migration inhibitory factor (MIF) is critical for the host resistance against Toxoplasma gondii. FASEB J. 2008, 22:3661-3671.
18. Gazzinelli R.T., Wysocka M., Hayashi S., Denkers E.Y., Hieny S., Caspar P., Trinchieri G., Sher A. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 1994, 153:2533-2543.
19. Homan W.L., Vercammen M., De Braekeleer J., Verschueren H. Identification of a 200- to 300-fold repetitive 529 bp DNA fragment in Toxoplasma gondii, and its use for diagnostic and quantitative PCR. Int. J. Parasitol. 2000, 30:69-75.
20. Igarashi I., Taguchi M., Suzuki N. Fundamental studies on macrophage migration inhibitory factor(s) in the supernatant from spleen cells in mice infected with Toxoplasma gondii. Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale 1979, 244:374-382.
21. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., Steinman R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 1992, 176:1693-1702.
22. Liu C.H., Fan Y.T., Dias A., Esper L., Corn R.A., Bafica A., Machado F.S., Aliberti J. Cutting edge: dendritic cells are essential for in vivo IL-12 production and development of resistance against Toxoplasma gondii infection in mice. J. Immunol. 2006, 177:31-35.
23. Manickasingham S.P., Edwards A.D., Schulz O., Reis e Sousa C. The ability of murine dendritic cell subsets to direct T helper cell differentiation is dependent on microbial signals. Eur. J. Immunol. 2003, 33:101-107.
24. Michelsen K.S., Aicher A., Mohaupt M., Hartung T., Dimmeler S., Kirschning C.J., Schumann R.R. The role of toll-like receptors (TLRs) in bacteria-induced maturation of murine dendritic cells (DCS). Peptidoglycan and lipoteichoic acid are inducers of DC maturation and require TLR2. J. Biol. Chem. 2001, 276:25680-25686.
25. 2-production as a sensitive and rapid assay for the quantitation of murine IFN-gamma. J. Immunol. Methods 1991, 139:107-114.
26. Mizue Y., Ghani S., Leng L., McDonald C., Kong P., Baugh J., Lane S.J., Craft J., Nishihira J., Donnelly S.C., Zhu Z., Bucala R. Role for macrophage migration inhibitory factor in asthma. Proc. Natl. Acad. Sci. USA 2005, 102:14410-14415.
27. Mun H.S., Aosai F., Norose K., Chen M., Piao L.X., Takeuchi O., Akira S., Ishikura H., Yano A. TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection. Int. Immunol. 2003, 15:1081-1087.
28. Murakami H., Akbar S.M., Matsui H., Horiike N., Onji M. Macrophage migration inhibitory factor activates antigen-presenting dendritic cells and induces inflammatory cytokines in ulcerative colitis. Clin. Exp. Immunol. 2002, 128:504-510.
29. Noels H., Bernhagen J., Weber C. Macrophage migration inhibitory factor: a noncanonical chemokine important in atherosclerosis. Trends Cardiovasc. Med. 2009, 19:76-86.
30. Pan J.H., Sukhova G.K., Yang J.T., Wang B., Xie T., Fu H., Zhang Y., Satoskar A.R., David J.R., Metz C.N., Bucala R., Fang K., Simon D.I., Chapman H.A., Libby P., Shi G.P. Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 2004, 109:3149-3153.
31. Ponchel F., Toomes C., Bransfield K., Leong F.T., Douglas S.H., Field S.L., Bell S.M., Combaret V., Puisieux A., Mighell A.J., Robinson P.A., Inglehearn C.F., Isaacs J.D., Markham A.F. Real-time PCR based on SYBR-Green I fluorescence: an alternative to the TaqMan assay for a relative quantification of gene rearrangements, gene amplifications and micro gene deletions. BMC Biotechnol. 2003, 3:18.
32. Reis e Sousa C., Hieny S., Scharton-Kersten T., Jankovic D., Charest H., Germain R.N., Sher A. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 1997, 186:1819-1829.
33. Renshaw M., Rockwell J., Engleman C., Gewirtz A., Katz J., Sambhara S. Cutting edge: impaired Toll-like receptor expression and function in aging. J. Immunol. 2002, 169:4697-4701.
34. Reyes J.L., Terrazas L.I., Espinoza B., Cruz-Robles D., Soto V., Rivera-Montoya I., Gomez-Garcia L., Snider H., Satoskar A.R., Rodriguez-Sosa M. Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection. Infect. Immun. 2006, 74:3170-3179.
35. Rodriguez-Sosa M., Rosas L.E., David J.R., Bojalil R., Satoskar A.R., Terrazas L.I. Macrophage migration inhibitory factor plays a critical role in mediating protection against the helminth parasite Taenia crassiceps. Infect. Immun. 2003, 71:1247-1254.
36. Roger T., David J., Glauser M.P., Calandra T. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 2001, 414:920-924.
37. Saavedra R., Leyva R., Tenorio E.P., Haces M.L., Rodriguez-Sosa M., Terrazas L.I., Herion P. CpG-containing ODN has a limited role in the protection against Toxoplasma gondii. Parasite Immunol. 2004, 26:67-73.
38. Sanchez, Y., Rosado, J., Vega, L., Elizondo, G., Estrada-Muñiz, E., Saavedra, R., Juarez, I., Rodriguez-Sosa, M., 2010. The unexpected role for the aryl hydrocarbon receptor on susceptibility to experimental toxoplasmosis. J. Biomed. Biotechnol. 505694 (15 pages).
39. Santos L.L., Morand E.F. The role of macrophage migration inhibitory factor in the inflammatory immune response and rheumatoid arthritis. Wien. Med. Wochenschr. 2006, 156:11-18.
40. Satoskar A.R., Bozza M., Rodriguez Sosa M., Lin G., David J.R. Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection. Infect. Immun. 2001, 69:906-911.
41. Shaw M.H., Reimer T., Sanchez-Valdepenas C., Warner N., Kim Y.G., Fresno M., Nunez G. T cell-intrinsic role of Nod2 in promoting type 1 immunity to Toxoplasma gondii. Nat. Immunol. 2009, 10:1267-1274.
42. Stavitsky A.B., Metz C., Liu S., Xianli J., Bucala R. Blockade of macrophage migration inhibitory factor (MIF) in Schistosoma japonicum-infected mice results in an increased adult worm burden and reduced fecundity. Parasite Immunol. 2003, 25:369-374.
43. Sukhumavasi W., Egan C.E., Warren A.L., Taylor G.A., Fox B.A., Bzik D.J., Denkers E.Y. TLR adaptor MyD88 is essential for pathogen control during oral Toxoplasma gondii infection but not adaptive immunity induced by a vaccine strain of the parasite. J. Immunol. 2008, 181:3464-3473.
44. Yarovinsky F., Zhang D., Andersen J.F., Bannenberg G.L., Serhan C.N., Hayden M.S., Hieny S., Sutterwala F.S., Flavell R.A., Ghosh S., Sher A. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 2005, 308:1626-1629.
45. Yarovinsky F., Sher A. Toll-like receptor recognition of Toxoplasma gondii. Int. J. Parasitol. 2006, 36:255-259.
46. Yoshida A., Maruyama H., Kumagai T., Amano T., Kobayashi F., Zhang M., Himeno K., Ohta N. Schistosoma mansoni infection cancels the susceptibility to Plasmodium chabaudi through induction of type 1 immune responses in A/J mice. Int. Immunol. 2000, 12:1117-1125.